BTIG Maintains Buy on Medtronic, Lowers Price Target to $99
Benzinga Newsdesk 2 weeks ago
Analyst RatingsNewsPrice TargetHot
BTIG analyst Ryan Zimmerman maintains Medtronic (NYSE:MDT) with a Buy and lowers the price target from $100 to $99.
BTIG analyst Ryan Zimmerman maintains Medtronic (NYSE:MDT) with a Buy and lowers the price target from $100 to $99.